News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
880,432 Results
Type
Article (88599)
Company Profile (815)
Press Release (790985)
Multimedia
Podcasts (228)
Webinars (34)
Section
Business (233515)
Career Advice (4158)
Deals (39950)
Drug Delivery (172)
Drug Development (91617)
Employer Resources (207)
FDA (18522)
Job Trends (17472)
News (398538)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3043)
Academic (2)
Accelerated approval (48)
Adcomms (39)
Allergies (184)
Alliances (56987)
ALS (222)
Alzheimer's disease (1930)
Antibody-drug conjugate (ADC) (495)
Approvals (18807)
Artificial intelligence (810)
Autoimmune disease (308)
Automation (59)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (237)
Biotechnology (486)
Bladder cancer (196)
Brain cancer (80)
Breast cancer (791)
Cancer (6144)
Cardiovascular disease (527)
Career advice (3590)
Career pathing (48)
CAR-T (360)
CDC (75)
Celiac Disease (3)
Cell therapy (1005)
Cervical cancer (48)
Clinical research (78406)
Collaboration (2247)
Company closure (8)
Compensation (1426)
Complete response letters (101)
COVID-19 (3029)
CRISPR (119)
C-suite (1189)
Cystic fibrosis (163)
Data (7960)
Decentralized trials (3)
Denatured (86)
Depression (185)
Dermatology (86)
Diabetes (632)
Diagnostics (7504)
Digital health (61)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (394)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (302)
Earnings (102164)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137515)
Executive appointments (1158)
FDA (22385)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1841)
Gene editing (260)
Generative AI (86)
Gene therapy (817)
GLP-1 (1244)
Government (5542)
Grass and pollen (8)
Guidances (413)
Healthcare (21088)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (344)
Immuno-oncology (103)
Indications (189)
Infectious disease (3403)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (300)
Interviews (820)
IPO (17990)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (22)
Labor market (111)
Layoffs (678)
Leadership (49)
Legal (10171)
Liver cancer (107)
Longevity (35)
Lung cancer (804)
Lymphoma (437)
Machine learning (63)
Management (66)
Manufacturing (1134)
MASH (202)
Medical device (15224)
Medtech (15345)
Mergers & acquisitions (23212)
Metabolic disorders (1682)
mRNA (243)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (466)
Neuropsychiatric disorders (125)
Neuroscience (3572)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5137)
Now hiring (78)
Obesity (817)
Opinion (366)
Ovarian cancer (227)
Pain (273)
Pancreatic cancer (310)
Parkinson's disease (386)
Partnered (39)
Patents (624)
Patient recruitment (695)
Peanut (67)
People (67734)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24225)
Phase 2 (34058)
Phase 3 (25616)
Pipeline (8649)
Policy (384)
Postmarket research (3558)
Preclinical (10900)
Press Release (72)
Prostate cancer (310)
Psychedelics (68)
Radiopharmaceuticals (351)
Rare diseases (1189)
Real estate (7457)
Recruiting (81)
Regulatory (30081)
Reports (77)
Research institute (2763)
Resumes & cover letters (653)
Rett syndrome (37)
RNA editing (27)
RSV (98)
Schizophrenia (191)
Series A (313)
Series B (224)
Service/supplier (30)
Sickle cell disease (120)
Special edition (31)
Spinal muscular atrophy (188)
Sponsored (55)
Startups (4363)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (139)
Vaccines (1265)
Venture capital (122)
Weight loss (563)
Women's health (131)
Worklife (24)
Date
Today (184)
Last 7 days (993)
Last 30 days (3535)
Last 365 days (33098)
2026 (12781)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (100)
Alaska (7)
Arizona (389)
Arkansas (16)
Asia (52076)
Australia (9159)
California (13674)
Canada (3837)
China (1440)
Colorado (589)
Connecticut (605)
Delaware (418)
Europe (120064)
Florida (2023)
Georgia (446)
Hawaii (4)
Idaho (69)
Illinois (1171)
India (97)
Indiana (635)
Iowa (25)
Japan (549)
Kansas (140)
Kentucky (56)
Louisiana (46)
Maine (88)
Maryland (1673)
Massachusetts (9982)
Michigan (409)
Minnesota (762)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (147)
New Hampshire (92)
New Jersey (3643)
New Mexico (34)
New York (3581)
North Carolina (1852)
North Dakota (11)
Northern California (6742)
Ohio (424)
Oklahoma (26)
Oregon (55)
Pennsylvania (2716)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5348)
Tennessee (216)
Texas (2212)
United States (48988)
Utah (409)
Vermont (1)
Virginia (353)
Washington D.C. (88)
Washington State (1128)
West Virginia (4)
Wisconsin (152)
Wyoming (2)
There are 880,432 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Infinitopes Appoints Immuno-Oncology Pioneer Jo Brewer as Chief Scientific Officer (CSO) to Advance Therapeutic Pipeline From Clinical to Commercialisation
May 12, 2026
·
5 min read
Press Releases
Enterprise Therapeutics Achieves Primary Efficacy Outcome in Phase 2 Clinical Trial for Cystic Fibrosis With Novel Inhaled ENaC Blocker ETD001
May 12, 2026
·
4 min read
Press Releases
New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden
May 12, 2026
·
10 min read
Press Releases
Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs
May 12, 2026
·
3 min read
Press Releases
AstronauTx builds executive team with appointment of experienced clinical development leader Michelle Mellion, MD as Chief Medical Officer
May 12, 2026
·
3 min read
Press Releases
Enterome presents Phase 2 indolent non-Hodgkin lymphoma data at EHA showing EO2463 induces B cell target-specific CD8 T-cell expansion correlating with clinical outcomes
May 12, 2026
·
4 min read
Press Releases
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
May 12, 2026
·
11 min read
Press Releases
Merz Therapeutics’ Activities at ISPRM 2026 Highlight the Importance of Patient-Centric Management in Upper and Lower Limb Spasticity: From Goal Setting to Optimal Dosing for Better Patient Outcomes
May 12, 2026
·
5 min read
Press Releases
GIP Moves from Supporting Role to Key Variable: BrightGene Bio-Medical’s Phase III Results Signal Differentiation in Weight Loss Arena
May 12, 2026
·
8 min read
Press Releases
Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity
May 12, 2026
·
8 min read
1 of 88,044
Next
